Clik here to view.
AI Medical Service Inc. Signs Joint Research Agreement with Mahidol...
TOKYO AI MEDICAL SERVICE INC. (hereinafter AIM), a medical start-up specializing in the development of diagnostic endoscopic AI, signed a joint research agreement with Mahidol University in Thailand...
View ArticleClik here to view.
AI Medical Service Inc.与泰国玛希隆大学签署联合研究协议
东京 (美国商业资讯)– 专门从事内窥镜诊断人工智能技术开发的医疗初创企业AI MEDICAL SERVICE INC.（以下简称“AIM”）于2024年3月1日与泰国玛希隆大学（以下简称“玛希隆大学”）签署了联合研究协议，并于2024年4月1日开始研究活动。AIM是首家与玛希隆大学签署内窥镜人工智能领域联合研究协议的日本企业，玛希隆大学则是迄今为止AIM合作的首家泰国研究机构1。...
View ArticleClik here to view.
joimax® Obtains Registration for All Products in the Indian Market
KARLSRUHE, Germany German-based joimax®, the market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, is excited to announce the full...
View ArticleClik here to view.
Recruiting Participants for the 365mc Global Social Contribution Campaign...
SEOUL, South Korea The leading obesity treatment medical institution in South Korea presents a second chance at life to obesity patients around the world. This press release features multimedia....
View ArticleClik here to view.
ENDRA Life Sciences Strengthens Intellectual Property with Issuance of Five...
ANN ARBOR, Mich. ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces the issuance of five new patents, including three in Europe and two in...
View ArticleClik here to view.
KKR to Acquire Healthium from Apax Funds
MUMBAI, India KKR, a leading global investment firm, today announced the signing of definitive agreements under which funds managed by KKR will acquire Healthium Medtech Ltd. (“Healthium”), a...
View ArticleClik here to view.
Qihan Biotech Appoints Yingyong Xu as its Chief Medical Officer
HANGZHOU, China Hangzhou Qihan Biotech Co., Ltd. (“Qihan” or “Qihan Biotech” or “the Company”), an industry leader in applying multiplexable genome editing technology to cell therapies and organ...
View ArticleClik here to view.
Optiscan与Mayo Clinic签署专门技术协议
澳大利亚墨尔本 (美国商业资讯)– Optiscan Imaging Limited (ASX:OIL) (以下简称“ Optiscan”或“公司”) 欣然宣布，公司与Mayo Clinic签订专门技术协议并达成合作，共同开发用于机器人手术的数字共焦激光内窥镜成像系统。 此次合作将Optiscan在数字内窥镜硬件和软件开发方面的工程专长与Mayo...
View ArticleClik here to view.
Optiscan、メイヨー・クリニックとノウハウ契約を締結
オーストラリア、メルボルン （ビジネスワイヤ） — Optiscan Imaging Limited（ASX：OIL）（以下「Optiscan」または「当社」）は、ロボット手術に使用するデジタル共焦点レーザー内視鏡画像システムを開発するため、メイヨー・クリニックとノウハウ契約による共同研究を開始したことを発表しました。...
View ArticleClik here to view.
ラピッド・メディカル™が世界初のロボット血栓除去装置で虚血性脳卒中手技を成功裏に完了
イスラエル・ヨクナム／ダラス （ビジネスワイヤ） — 先進的な神経血管装置の有数の開発企業であるラピッド・メディカル™は、コロンビアのメデジンで初のロボットによる血栓除去術を成功させたことを発表いたします。患者の解剖学的構造に自律的に適応する初の血管内血栓除去装置であるロボットのタイガートリーバー™を用いて、2名の患者に治療を行いました。...
View ArticleClik here to view.
Rapid Medical™使用全球首台机器人血栓切除设备成功完成缺血性中风手术
以色列约克尼姆和达拉斯 (美国商业资讯)– 先进神经血管设备的领先开发商Rapid Medical ™宣布在哥伦比亚麦德林成功实施首例机器人血栓切除术。两名患者接受了机器人TIGERTRIEVER™的治疗，这是第一种能够自主适应患者解剖结构的血管内血栓切除设备。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
joimax® Unveils New Website, Celebrates 20 Years of TESSYS® at Global Spine...
KARLSRUHE, Germany German-based joimax®, the market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, announces the launch of its new website...
View ArticleClik here to view.
ASP Japan合同会社とＨＯＹＡグループPENTAX Europe...
東京 （ビジネスワイヤ） — 2024年5月27日、ASP Japan合同会社（以下、ASP Japan）はＨＯＹＡグループPENTAX Europe GmbH（以下、PENTAX Medical）と、軟性内視鏡乾燥保管システム『PlasmaTYPHOON™＋』及び軟性内視鏡ブラシレス自動予備洗浄システム『AquaTYPHOON™』（製造業者：PlasmaBiotics...
View ArticleClik here to view.
Clik here to view.
エルベ・エレクトロメディジン、ドイツのランゲンディンゲンに医療機器のための新しいコンピテンスセンターを開設し、世界中の顧客のために能力を拡大
テュービンゲン、ドイツ （ビジネスワイヤ） —...
View ArticleClik here to view.
Anteris Provides Update on DurAVR™ THV Valve-in-Valve Experience Presented at...
BRISBANE, Australia & EAGAN, Minn. Anteris Technologies Ltd (ASX: AVR), a structural heart company developing DurAVR™ THV, a new class of TAVR and the world’s only balloon-expandable,...
View ArticleClik here to view.
Takeda Announces Approval of LIVTENCITY® (maribavir) in Japan for...
OSAKA, Japan & CAMBRIDGE, Mass. Takeda (TSE:4502/NYSE:TAK) today announced that LIVTENCITY® (maribavir) has been approved by the Japanese Ministry of Health, Labour and Welfare (MHLW) for...
View ArticleClik here to view.
Imricor’s VISABL-AFL Trial for US FDA Approval Commences at Cardiovascular...
MINNEAPOLIS Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in real-time iCMR cardiac ablation products, is pleased to announce that the Vision-MR Ablation Catheter...
View ArticleClik here to view.
Anteris Technologies and v2vmedtech Announce Concept Lock of Next Generation...
BRISBANE, Australia & EAGAN, Minn. Anteris Technologies Ltd (ASX: AVR), a structural heart company developing DurAVR™ THV, a new class of TAVR and the world’s only balloon-expandable,...
View ArticleClik here to view.
Reflow Medical Enrolls First Patients in Pilot Study of Coronary...
SAN CLEMENTE, Calif. Reflow Medical, Inc., a developer of innovative devices focused on cardiovascular disease, announces the first patient enrollments in “A pilot study of the Drug-Eluting Coronary...
View Article